Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 85%
filed 2026-07-02
The filing discloses an unregistered issuance of 3,500 shares of newly created Series A Preferred Stock in exchange for cancellation of $3.5 million of a pre-paid purchase obligation. The Exchange Shares were issued pursuant to Section 3(a)(9) of the Securities Act and have not been registered, representing a dilutive equity issuance. While structured as an exchange rather than a cash raise, this is a material capital restructuring that dilutes common shareholders' interests and subordinates their rights to the senior preferred stock with 9% annual preferred returns and liquidation preferences.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-02
Item 5.07 discloses the results of Ernexa Therapeutics' 2026 Annual Meeting of Stockholders held on July 1, 2026, with detailed voting tallies for three proposals: election of five directors (Proposal 1), ratification of Haskell & White LLP as independent auditor (Proposal 2), and approval of the 2026 Omnibus Equity Incentive Plan (Proposal 3). This is a standard shareholder vote results disclosure that would materially inform investors about board composition and governance matters.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-02
AI Financial Corporation received a Nasdaq notification on July 1, 2026, that it failed to maintain the minimum closing bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days. The company has 180 calendar days (until December 28, 2026) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting the registrant's continued listing status.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Raymond W. Cohen, a Class III board member and member of both the Audit Committee and Compensation Committee, tendered his resignation effective July 1, 2026. The filing explicitly discloses this departure under Item 5.02 and confirms the resignation was for personal considerations with no disagreement with the Company. Board departures, particularly from committee members, are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-07-02
The filing discloses termination of a material Technology License and Development Agreement with LightSolver dated September 2, 2025, effective June 26, 2026. The agreement granted exclusive rights to commercialize proprietary laser processing hardware and technology for cryptocurrency mining. The termination represents a material change in the Company's business relationships and strategic direction, coupled with the announced pivot to optical computing initiatives. While Item 1.02 addresses termination of a material definitive agreement (distinct from M&A), the substance reflects a significant business restructuring that materially affects the registrant's operations and strategic focus.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
The filing discloses that Bruce Czachor, the Company's General Counsel, Chief Compliance Officer and Secretary, will depart on January 25, 2027, as the Company will not renew his Executive Employment Agreement dated January 26, 2026. This is a departure of a named executive officer holding multiple senior compliance and governance roles, which is material to investors' assessment of the registrant's leadership and governance structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-02
The filing discloses a Letter Agreement dated June 29, 2026, under Item 1.01 and Item 3.02, involving the issuance of 255,267 shares of Common Stock from abeyance, a pre-funded warrant covering 251,987 shares, and a new warrant to purchase 1,268,135 shares at $2.14 per share. These are unregistered equity issuances (exempt under Section 4(a)(2) and Regulation D) that are dilutive to existing shareholders and represent a material capital structure transaction.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-02
The filing discloses two material debt transactions: (1) a $152,950 promissory note from 1800 Diagonal Lending with $125,000 net proceeds and a 150% acceleration clause upon default, and (2) exchange agreements with Streeterville Capital partitioning a $5.47M note into three new secured promissory notes totaling $383,000. Item 2.03 explicitly incorporates the debt obligations, and Item 1.01 describes entry into material definitive agreements creating direct financial obligations. While the Streeterville transaction also involves equity issuance (Item 3.02), the primary disclosed event is the creation of new debt instruments.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Scott Henry, a member of NexGel's Board of Directors and Chairperson of the Audit Committee, notified the Company on June 29, 2026 of his intent to resign effective July 1, 2026. The filing explicitly states his resignation is to "lighten his schedule and give attention to other business ventures and personal matters" and confirms no disagreement with the Company. This is a clear executive departure under Item 5.02, material because the loss of an audit committee chair affects governance and investor confidence.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-02
The filing discloses a written notice from Nasdaq on June 29, 2026, that Callan JMB Inc. has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The Company has been granted a 180-day compliance period (until December 28, 2026) to regain compliance, with potential delisting if it fails to do so. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-02
The filing discloses termination of a Master Services Agreement with Smoker Friendly International, LLC effective 180 days from July 1, 2026, under which the Company manufactures cigarette and cigar products. This is a material operational event involving loss of a significant customer relationship, but does not fit the specific categories of M&A activity, debt covenant breach, or other named event types. The termination is for convenience with no early termination penalties, making it a strategic business decision rather than a distress event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-02
FatPipe Inc entered into an At-The-Market (ATM) Sales Agreement with H.C. Wainwright & Co. on July 2, 2026, authorizing the sale of up to $10,000,000 in common stock shares. This is a classic dilutive equity issuance disclosed under Item 1.01 (Entry into a Material Definitive Agreement). The ATM structure allows the company to sell shares opportunistically at market prices, which is material to investors as it signals potential capital raising and shareholder dilution.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-02
The filing discloses entry into a Securities Exchange Agreement effective June 30, 2026, whereby Beeline Financial Holdings (a subsidiary of Beeline Holdings) acquired all remaining shares of MagicBlocks, Inc., converting it from a 47.6%-owned subsidiary into a wholly-owned subsidiary. The transaction involved issuance of 211,679 shares of common stock to Third-Party SAFE Holders in exchange for approximately $476,277 in aggregate principal, plus employment agreements with the Selling Shareholders. This constitutes a material acquisition/change of control under Item 1.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-02
The filing discloses results of Akari's Annual General Meeting held on June 30, 2026, including voting outcomes on 16 resolutions covering board re-elections, auditor appointments, executive compensation, and equity issuances. Notably, director James Neal failed to receive requisite shareholder approval and was not re-elected, triggering his departure from the board and his committee roles. This is a classic Item 5.07 shareholder vote results disclosure with material governance consequences.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
The filing discloses the resignations of two senior executives: James Christodoulou (Chief Financial Officer and Chief Accounting Officer) effective June 26, 2026, and David Scott (Interim Chief Executive Officer) effective June 30, 2026. While both departures are disclosed, the principal event is the departure of these officers from their roles. The filing explicitly states these resignations "align with the previously announced discontinuation of the Company's artificial intelligence research and development activities," indicating a strategic restructuring. The departure of a CFO and interim CEO are material events affecting investor assessment of the company's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-07-02
Item 5.02
Stacia Hansen's resignation as Chief Accounting Officer effective June 12, 2026, is the principal disclosed action. While the filing also describes severance terms ($108,333) and a separation agreement, the core event is the departure of a named officer. The severance disclosure is ancillary to the departure itself, making exec_departure the most salient classification.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-02
Item 3.01
FingerMotion received a deficiency letter from Nasdaq on June 30, 2026, notifying the company that its stock price has fallen below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company has 180 calendar days until December 28, 2026, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
Pembina announces a positive final investment decision (FID) on the Greenlight Electricity Centre, a 932 MW gas-fired power generation facility representing a ~$2.1 billion net investment to Pembina (47.5% ownership). This is a material strategic expansion into a new business line (power-to-data-centre) that fits Pembina's 3C strategy and is expected to generate ~$310 million annual run-rate adjusted EBITDA. While the disclosure involves a joint venture formation with MSIP and Kineticor, the primary event is the operational/strategic decision to proceed with a major new infrastructure project, not an M&A transaction per se. This is classified as operational_other because it represents a material strategic business expansion and new platform development that does not fit the specific M&A category (which typically applies to acquisitions or dispositions of existing entities rather than greenfield project development).
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
Pembina has entered into a non-binding Heads of Agreement to participate in a proposed nation-building crude oil pipeline and export terminal project connecting Alberta to Canada's West Coast. This is a material strategic partnership and infrastructure initiative that would give Pembina a 10% economic interest during construction with potential for an additional 10% at commercial operations. While not a completed M&A transaction (which would be `ma_activity`), this represents a significant operational and strategic commitment involving government partnerships, substantial capital deployment, and long-term infrastructure development that would materially affect investor assessment of the company's growth strategy and capital allocation.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-02
EX-99.1
This press release announces clinical trial results validating Trinity Biotech's CGM+ wearable biosensor technology's ability to distinguish nocturnal compression-related false lows from true blood glucose lows, based on analysis of over 5,000 hours of clinical wear data. The disclosure demonstrates a material product development milestone and technological differentiation within the $15 billion global CGM market, supporting the company's commercial strategy for its next-generation platform. While not a discrete M&A, financing, or governance event, this operational milestone regarding a key product capability would affect a reasonable investor's assessment of the company's competitive positioning and commercialization prospects.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-07-02
Item 8.01
News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transaction details including 8.8 million Class A shares and 70,004 Class B shares purchased on the prior day for approximately $223.8 million in aggregate consideration. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category as they represent a return of capital, distinct from operational or financial events. The filing is material as it reflects significant capital deployment and shareholder value distribution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-02
Item 5.02
UPAY, Inc. appointed Wynand Johannes Jordaan as a non-executive director effective July 1, 2026. The appointment includes a compensatory arrangement of 200,000 restricted shares vesting over 24 months and is intended to strengthen the board's technology, software architecture, systems design, and digital infrastructure expertise.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-02
Item 8.01
Civeo priced $100.0 million aggregate principal amount of 4.50% Convertible Senior Notes due 2031 in a private offering, with net proceeds of approximately $96.2 million to be used for debt repayment and share repurchases.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
Prashanth Mahendra-Rajah resigned from Shopify's board of directors effective immediately on July 2, 2026. As a board member and Chair of the Audit Committee, his departure is material to investors. The disclosure centers on the principal action of a director leaving the company to accept a full-time position elsewhere, which is the defining characteristic of an exec_departure event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-02
Item 7.01
The filing discloses receipt of all required regulatory approvals to complete a pending acquisition of Avanos Medical by affiliates of American Industrial Partners, with closing expected by July 27, 2026, subject to stockholder approval. This is a material acquisition event that materially affects the registrant's status and future ownership structure. The press release explicitly states this is a "pending acquisition" and "Merger," and the transaction is expected to close imminently following stockholder approval.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-02
Item 1.01
NextDecade's subsidiary Rio Grande LNG completed the issuance of $3.5 billion in aggregate principal amount of senior secured notes across four tranches (2031, 2034, 2036, and 2041 maturities) pursuant to an indenture dated July 2, 2026, with proceeds intended to repay existing credit facility borrowings.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-02
Item 7.01
The filing discloses the closing of the previously announced acquisition of WTech Fire Group on July 1, 2026. The press release explicitly states "APi Group Corporation (NYSE: APG) announced that on July 1, 2026, it closed the acquisition of WTech Fire Group." The acquisition adds $175 million in annual revenue and prompts the company to raise its full-year 2026 financial guidance, indicating material significance to the registrant.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-02
Item 5.02
The disclosure centers on compensatory arrangements for two named executives: Kevin Moran's amended employment agreement increasing his base salary to $600,000 and setting his 2026 target bonus at $1,600,000, and Nancy Curtin's new employment agreement as Interim CEO. While the Moran amendment also updates his title, the substantive focus is on salary, bonus, and equity award treatment modifications. This is a classic Item 5.02(e) compensation disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 2.02
Tesla disclosed Q2 2026 production (451,758 vehicles), deliveries (480,126 vehicles), and energy storage deployments (13.5 GWh) via press release attached as Exhibit 99.1 under Item 2.02. Although full financial results will be announced on July 22, 2026, this disclosure of operational metrics and production/delivery figures is a standard earnings-related announcement that would materially inform investors about the company's operational performance and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-07-02
Item 2.02
Lucid Group issued a press release announcing Q2 2026 production and delivery totals of 4,774 vehicles produced and 3,953 delivered.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 88%
filed 2026-07-02
Item 5.02
Lucid announced multiple senior executive appointments to its Global Leadership Team, including Alexander De Bock as Chief Financial Officer (with $750,000 base salary, $1.1M signing bonus, $7.5M equity grants, and up to $2.5M performance-based bonuses), Raja Ramana Macha as Chief Technology Officer, Billy Hayes as Chief Customer Officer, Hugo Martinho as Chief Transformation Officer, Kay Stepper as Chief Digital Officer, and a promotion of Christian Appel, alongside the departure of incumbent CFO Taoufiq Boussaid. These appointments are intended to simplify the organization, sharpen accountability, and improve execution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-02
Item 3.02
The Company completed an unregistered private placement of 352,179 Class J common shares for approximately $7.1 million under Section 4(a)(2) and Regulation D Rule 506, and issued 3,259.24 Class E common shares to an affiliate as payment for advisory fees, representing a significant dilutive equity issuance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-02
Item 7.01
The Company declared distributions to shareholders of both Class J and Class E common shares at $0.17 per share, payable on or about July 20, 2026, with a record date and reinvestment plan option available.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-02
Item 1.01
Centrus signed a material definitive contract with the U.S. Department of Energy on June 30, 2026, establishing a $900 million firm fixed-price agreement to deploy HALEU enrichment capacity with performance-based milestone payments through March 2032, plus options for up to $170 million in additional purchases (total contract value $1.07 billion with all options). This represents a significant material transaction that would affect investor assessment of the company's revenue prospects, capital deployment, and strategic positioning in the domestic uranium enrichment market.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-02
Item 5.02
The disclosure centers on compensatory arrangements for three named executives: base salary increases for Burnette (from $425k to $525k), Datta (from $400k to $450k), and Wiesinger (from $400k to $450k); an increase in Burnette's annual incentive bonus opportunity from 80% to 100% of base salary; and substantial equity grants totaling $12 million in restricted stock units under the 2025 Equity Incentive Plan, plus a replacement RSU grant to Datta in exchange for cancellation of a prior option. These are material compensation modifications approved by the Compensation Committee on July 1, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 72%
filed 2026-07-02
Item 1.01
Backblaze amended its credit agreement with Citizens Bank to expand the indebtedness threshold for capital leases to $150 million. While technically an amendment to an existing facility rather than a new debt issuance, this modification materially increases the Company's borrowing capacity and financial obligations, making it a significant capital structure event. The amendment signals the Company's intent to leverage capital leases as a financing mechanism, which is a material financial obligation creation event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-02
Item 1.01
Abacus Global Management entered into a First Amendment to its Credit Agreement on June 29, 2026, under which lenders agreed to provide incremental term loans of $75,000,000, increasing total aggregate principal from $150,000,000 to $225,000,000.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
Sean McNealy resigned from his role as a director of Abacus Global Management, Inc., effective June 30, 2026, in connection with his planned retirement, with planned resignation from all subsidiary roles by December 31, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-02
Item 1.01
TD SYNNEX entered into a European receivables securitization program on June 26, 2026, creating a new direct financial obligation through the issuance of senior and junior notes with an aggregate committed facility of EUR 650 million. This is a material debt issuance under Item 1.01, distinct from a covenant breach or other financial event, as it represents the creation of new financing obligations with defined terms, interest accrual, and amortization schedules extending to June 2028 (potentially 2031).
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
Marcy Klevorn resigned from the Board of Directors effective July 1, 2026, after notifying the Board on June 28, 2026. She served on the Compensation Committee and Nominating and Governance Committee. Board departures are material governance events affecting the composition and oversight structure of the company, and the filing explicitly discloses this resignation under Item 5.02 as a director departure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-07-02
Item 5.02
The disclosure centers on compensatory arrangements for Mr. Loïc Eloy, a named executive officer and President of Nuclear & Safety Group, including a specified annual base salary of USD 415,000, a 50% target bonus opportunity, and customary expatriation-related benefits (housing, relocation, education, travel, tax and social protection). While the filing is under Item 5.02, the principal action disclosed is the modification of his compensation package in connection with his secondment assignment, not a departure or appointment to a new role.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-02
Item 7.01
The Board approved an extension of DocGo's share repurchase program from June 30, 2026 to December 31, 2026, allowing continued discretionary purchases of up to $26 million in common stock. While share repurchases are technically distinct from dividends, they constitute a return of capital to shareholders and fall within the dividend_distribution taxonomy as a capital allocation mechanism. The extension of an existing program with material dollar authorization qualifies as material to investors assessing capital allocation strategy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
This announcement discloses a successful Type B meeting with the FDA regarding the ProstACT Global Phase 3 trial of TLX591-Tx, with FDA alignment on advancement into Part 2 in the United States. The disclosure covers regulatory approval of the clinical protocol, statistical framework, and safety data sufficiency to proceed with U.S. enrollment. This is a material operational/regulatory milestone for a clinical-stage therapeutic candidate in a pivotal trial, affecting the company's development timeline and commercial prospects, but does not fit the specific event types (e.g., it is not a discrete M&A activity, earnings release, or executive change).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-02
Item 1.01
Haverty Furniture entered into a Sixth Amendment to its credit agreement, extending the maturity date of the Revolving Credit Facility to June 29, 2031, increasing aggregate commitments from $80 million to $100 million, and raising the swingline sublimit from $5 million to $10 million. This material modification expands the Company's borrowing capacity and extends its debt obligations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses multiple executive appointments effective July 1, 2026: Robert Wright appointed Chief Financial Officer (replacing Mark Hobbs), Misty Lavender appointed Executive Vice President, General Counsel and Corporate Secretary (replacing Denise McWatters), and Mohit Bhardwaj appointed to a new Executive Vice President, New Energy role. While the section also includes compensation amendments and a departure (McWatters transitioning to consulting), the principal disclosed actions center on the appointments of new officers to key leadership positions, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-02
Item 3.01
Boxlight received written notice from Nasdaq on July 1, 2026, that its securities are subject to suspension and delisting due to non-compliance with the $2.5 million stockholders' equity requirement under Nasdaq Listing Rule 5550(b). The company plans to request a hearing before the Nasdaq Hearings Panel but acknowledges "there can be no assurance that the Panel will grant the Company's request for continued listing." This is a direct delisting notice triggering Item 3.01 disclosure and represents a material threat to the company's continued public trading status.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 7.01
The filing discloses the Company's plan to issue its earnings release for the quarter ended June 30, 2026, on July 20, 2026, and host a conference call on July 21, 2026 with Chairman and CEO John W. Bordelon, President Darren E. Guidry, and CFO David T. Kirkley to discuss second quarter results. Although this is technically an announcement of a future earnings release rather than the release itself, the substance is a disclosure of material quarterly financial results, which is a standard earnings_release event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
This press release announces NMPA (China's drug regulator) conditional approval of ORPATHYS® (savolitinib) for MET-amplified gastric cancer, marking the third approved indication for the drug in China. The approval is a significant regulatory and commercial milestone for HUTCHMED's proprietary drug platform, supported by pivotal Phase II trial data published in Nature Medicine. While not a discrete M&A, financing, or governance event, this regulatory approval of a marketed therapeutic product represents a material operational and strategic achievement that would affect a reasonable investor's assessment of the company's pipeline execution and commercial prospects.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-07-02
The 6-K announces an update to a share buyback programme authorized to return up to €1 billion to shareholders. The second tranche of €500 million is expected to commence on 6 July 2026 and run through 18 December 2026, with Goldman Sachs acting as riskless principal. Share buyback programmes that return capital to shareholders are classified as dividend distributions under the taxonomy, and a €1 billion capital return programme is material to investors assessing the company's capital allocation and shareholder returns.
View raw filing on EDGAR →